Status:

UNKNOWN

Cholecalciferol on Depressive Symptoms in Type 2 Diabetes Mellitus Patients

Lead Sponsor:

Indonesia University

Conditions:

Diabetes Mellitus, Type 2

Depressive Symptoms

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

One in eleven adults falls ill with Diabetes Mellitus (DM) and 90% of them suffered from type 2 DM. Depression in type 2 DM patients had a big impact, acting as a major barrier to self-care in type 2 ...

Detailed Description

According to World Health Organization report's, depression was estimated causing distress in most people on 2030. 1 In Indonesia, the prevalence of depression in 2017 was 3,7%.2 Depression often foun...

Eligibility Criteria

Inclusion

  • Male or female subjects with aged 18 and over
  • Living in around Jakarta
  • Type 2 diabetes mellitus patients with depression symptom
  • Patients with Body mass index 20-30 m/kg2
  • Patients are able and willing to maintain diet, physical activity, and lifestyle for 3 months
  • Patients are able and willing to control for follow up

Exclusion

  • \- Presence of severe hepatic dysfunction, defined as cirrhosis hepatic
  • Presence of severe renal dysfunction, defined as chronic kidney disease stage 5 or e-GFR ≤15 or history of hemodialysis
  • Patients with acute coronary syndrome
  • Presence of acute systemic inflammatory response syndrome (SIRS). The term SIRS describes a clinical state arising from a non-specific cause, infective, or otherwise
  • Recent obtained vitamin D therapy within the last 3 months
  • Current or regular use of corticosteroids within immunosuppressant dosage
  • Presence of major depression
  • Presence of psychosis
  • Current or regular use of anti-depressant
  • Current or regular use of phenytoin or phenobarbital
  • For females: current pregnancy and lactation period
  • Patients who refuse the studies

Key Trial Info

Start Date :

January 18 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2021

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT04917458

Start Date

January 18 2021

End Date

October 1 2021

Last Update

June 8 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cipto Mangunkusumo National General Hospital

Jakarta Pusat, DKI Jakarta, Indonesia, 10430